I'll research LYV before writing the preview. Let me start by gathering recent earnings materials, news, and stock data.Let me read the most recent quarter's materials and check for recent news/filings.Let me get recent news context and the year-ago Q2 comparison base.Let me search for the latest developments (DOJ/antitrust, recent tours) heading into the print.Let me pull details from the preview and antitrust verdict articles.Let me get details on the antitrust verdict — a key overhang.# Live Nation Entertainment (LYV) — Q2 2026 Earnings Preview
LYV goes into this print near all-time highs. The stock closed at ~$183 on July 29, up roughly +28% year-to-date and +22% over the trailing 12 months — meaningfully outpacing the S&P 500 over the same window. That leaves little margin for error: expectations are elevated even as the reported growth rate is set to slow sharply.
The market's own reaction history underscores how binary these prints have become. The stock jumped +6.7% the day after the Q1 2026 beat (May), but fell ~11% after the Q3 2025 miss (November). Wall Street's short-term signals are mixed heading in — the consensus points to strong EPS growth, yet Zacks flags the name a Rank #5 ("Strong Sell") despite a positive Earnings ESP, so a beat is far from guaranteed.
| Metric | Q2 2026 Consensus | Q2 2025 Actual | Implied Y/Y |
|---|---|---|---|
| Revenue | ~$7.53B | $7.01B | +7.5% |
| Adjusted EPS | ~$0.59 | $0.41 | +44% |
The critical nuance: revenue growth is expected to decelerate to ~8% from +16% in the year-ago quarter. This is not (necessarily) a demand problem — it is largely calendar mechanics management telegraphed on the Q1 call and in the Q1 release.
Management was unusually explicit last quarter that growth this year skews to Q3 and Q4, so investors should be careful not to over-read a "soft-looking" Q2. From the Q1 disclosures:
Layered on top is a tough comp: Q2 2025 was a blockbuster — global attendance rose +14% to 44 million fans with stadium attendance tripling, and Concerts AOI jumped +33% to a record $359M. Lapping that, headline Q2 2026 concert metrics may look pedestrian even if the full-year story is fully intact.
Bottom line for the quarter: focus less on the absolute Q2 growth rate and more on (a) whether management reaffirms full-year double-digit AOI growth, and (b) forward indicators (deferred revenue, booked show counts) that validate the 2H acceleration thesis.
a) Forward indicators / deferred revenue. These have been the best tell on this business. In Q1, event-related deferred revenue hit a record $6.6B (+22%), and the company had already booked >85% of 2026 large-venue shows and sold >107M concert tickets (+11%). Watch for continued double-digit growth in deferred revenue and confirmation that the summer stadium/amphitheater slate is filling as expected. Management said in May they'd "talk in August," implying they'd have real-time reads on summer on-site spend and demand.
b) Concerts margin and mix. With Q2 mix tilted to third-party arenas, Concerts AOI margin could look flat-to-soft; the bigger margin story (owned amphitheaters, premium hospitality) is a 2H event. Watch on-site/per-fan spend — the Vinyl Room premium rollout was running >$100 per fan at the Hollywood Palladium.
c) Ticketmaster headwind. Management guided that its crackdown on broker/scalper inventory in the secondary market is a structural, one-time mid-single-digit AOI headwind for full-year 2026, with full-year Ticketing margin expected to be similar to last year. Watch primary fee-bearing ticket volume (guided to mid-single-digit growth) and whether elevated legal/compliance costs inside the segment are moderating as promised.
d) Sponsorship. The consistent bright spot — Q1 AOI +21%, with 85% of 2026 sponsorship already committed as of April. Expect continued double-digit AOI growth; any deceleration here would be a genuine surprise.
e) Venue Nation & capital allocation. FY26 capex is guided to $1.1–1.2B (~$800–850M for venues), partially offset by ~$250M of JV/sponsorship funding. The ~€610M venue-backed investment-grade securitization is a new funding vehicle worth understanding — it lets LYV lever the "propco" venue portfolio separately. Leverage sat at a comfortable 3.6x with $9.1B cash.
This is arguably the dominant swing factor for the stock, and the situation escalated materially in 2026:
What to listen for: any update on the remedies-phase schedule, the court's handling of the DOJ settlement vs. the states' verdict, and management's characterization of appeal timelines. Even incremental clarity (or additional accrual) could move the stock more than the operating results. Note the AOI figures management guides to exclude these litigation charges, so headline GAAP operating income will again look distorted (Q1 showed a $371M operating loss vs. $371M positive AOI).
Bull case: Structural live-demand story remains intact and global; deferred revenue at records; supply of touring artists expanding worldwide (Latin America, Asia, K-pop); Venue Nation and premium hospitality are multi-year margin/AOI compounding drivers; sponsorship growing 20%+; strong balance sheet and improving FCF conversion. Management continues to frame LYV as a "long-term compounding double-digit grower."
Bear case: Stock priced for perfection near highs; Q2 headline growth decelerating and lapping a monster comp; Ticketing facing a self-inflicted secondary headwind; capex ramping ($1.1B+); and — most importantly — an unresolved antitrust verdict with a live risk of a forced Ticketmaster breakup / amphitheater divestiture and additional damages.
Expect a quarter that looks decelerating on the surface (~8% revenue growth, ~$0.59 EPS) but that management will frame as fully on-track for double-digit full-year AOI growth, with the real inflection back-half loaded into the summer stadium/amphitheater season. The operating fundamentals will likely be fine-to-good; the reaffirmation of full-year guidance and forward booking/deferred-revenue metrics are the tell. But with the shares at highs, the tape-moving variable may be any news on the antitrust remedies phase, where the tail risk of structural separation looms larger than a single quarter's results. Watch the call commentary (August is when management said they'd have live summer reads) at least as closely as the printed numbers.
Note: Consensus figures are from third-party estimate aggregators and may differ modestly across providers; LYV does not give formal quarterly guidance.